Loading...
Current guidelines indicate that HIV-infected patients with CD4 counts <200 cells/mm3 should receive prophylaxis for Pneumocystis jirovecii pneumonia. But is this really necessary in patients on effective antiretroviral therapy? Dr. Paul Sax raises the question in his blog HIV and ID Observations.